Related Research Articles
Labcorp Drug Development is a contract research organization (CRO) headquartered in Burlington, North Carolina, providing nonclinical, preclinical, clinical and commercialization services to pharmaceutical and biotechnology industries. Formerly called Covance, the company is part of Labcorp, which employs more than 70,000 people worldwide. Labcorp Drug Development claims to provide the world's largest central laboratory network. Labcorp Drug Development has been met by fierce activism from animal rights leaders including Jane Goodall for its animal testing procedures.
Pharming, a portmanteau of "farming" and "pharmaceutical", refers to the use of genetic engineering to insert genes that code for useful pharmaceuticals into host animals or plants that would otherwise not express those genes, thus creating a genetically modified organism (GMO). Pharming is also known as molecular farming, molecular pharming or biopharming.
Biocon Limited is an Indian biopharmaceutical company that is based in Bangalore, India. It was founded by Kiran Mazumdar-Shaw in 1978. The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, including the United States and Europe. It also manufactures novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold in both bulk and formulation forms in several emerging markets. Syngene International Limited (Syngene) is a publicly listed subsidiary of Biocon, operating in the contract research services space.
In the life sciences, a contract research organization (CRO) is a company that provides support to the pharmaceutical, biotechnology, and medical device industries in the form of research services outsourced on a contract basis. A CRO may provide such services as biopharmaceutical development, biologic assay development, commercialization, clinical development, clinical trials management, pharmacovigilance, outcomes research, and Real world evidence.
The pharmaceutical industry is one of the leading industries in the People's Republic of China, covering synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China has the second-largest pharmaceutical market in the world as of 2017 which is worth US$110 billion. China accounts for 20% of the world's population but only a small fraction of the global drug market. China's changing health-care environment is designed to extend basic health insurance to a larger portion of the population and give individuals greater access to products and services. Following the period of change, the pharmaceutical industry is expected to continue its expansion.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 50% of all vaccines manufactured in the world. With industry standards compliant mega production capabilities and large number of skilled domestic workforce, Indian exports meet the standards and requirements of highly regulated markets of USA, UK, European Union and Canada. According to the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, domestic pharmaceutical market turnover reached Rs 129,015 crore in 2018, growing 9.4 per cent year-on-year and exports revenue was US$17.28 billion in FY18 and US$19.14 billion in FY19.
Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook, operates the Parexel-Academy, and councils all of the top 50 biopharmaceutical and top 30 biotechnology companies.
IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of $49 Billion as of August 2021. As of 2017, IQVIA was reported to be one of the world's largest contract research organizations.
A contract manufacturing organization (CMO), more recently referred to as a contract development and manufacturing organization (CDMO) to avoid the acronym confusion of Chief Medical Officer or Clinical Monitoring Organization in the pharma industry, is a company that serves other companies in the pharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing. This allows major pharmaceutical companies to outsource those aspects of the business, which can help with scalability or can allow the major company to focus on drug discovery and drug marketing instead.
Scrip Intelligence (Scrip) is an English language international pharmaceutical news, analysis and data service. First published as a weekly print newsletter in March 1972, Scrip included articles on side-effects, regulatory changes and mergers and acquisitions. Scrip World Pharmaceutical News was initially published by advertising company J Walter Thomson but was bought by Dr Philip J Brown in 1976 for £2000, who founded PJB Publishing. Brown sold Scrip, associated titles, and his company to Informa for £150 million in 2003. Scrip has now developed into an online global pharma news and analysis service. It provides daily news and analysis on the biotechnology and pharmaceutical industry including areas such as policy & regulation, business news, research & development, generics, drug delivery, and clinical trials.
WuXi AppTec is a global pharmaceutical, biopharmaceutical, and medical device company.
Christoph Westphal, M.D., Ph.D., is a biomedical entrepreneur.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai, Maharashtra, India. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.
Trevor Mervyn Jones, CBE PhD DSc (Hon) FRCP FMedSci FBPhS FRSM FRSC FLSW is a visiting professor at King's College London, and a former Head of R&D, at Wellcome. He continues to have a distinguished career in the pharmaceutical and biotech industry as well as in academia.
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
Spotlight Innovation Inc. is an American pharmaceutical holding company. The company currently maintains two subsidiaries: Caretta Therapeutics, Inc. and Celtic Biotech Iowa, Inc. Spotlight Innovation Inc. is based in Urbandale, Iowa and is publicly traded on the OTCQB marketplace under the stock ticker symbol, STLT.
The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry.
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Sanifit Therapeutics.
GenScript Biotech Corporation is a global biotechnology group, founded in New Jersey, United States in 2002, by Dr. Fangliang (Frank) Zhang, and listed on the Hong Kong Stock Exchange in 2015. Currently, the rotating CEO of GenScript is Dr. Zhenyu Liu., GenScript operates in over 100 countries and regions worldwide, with legal entities located in the US, China, Hong Kong, Japan, Singapore, the Netherlands, and Ireland. GenScript provides products and services to over 100,000 customers.,
References
- 1 2 3 4 5 6 7 8 9 "IQnovate Ltd". OTC Markets. Retrieved 10 May 2013.
- 1 2 "Innovation and strategies for pharmas, biotechs and the R&D community: IQnovate". BioPharma Australasia Conference. Retrieved 10 May 2013.
- 1 2 3 "Profile: IQnovate Ltd (IQNDY.PK)". Reuters. Archived from the original on 5 March 2016. Retrieved 10 May 2013.
- 1 2 3 4 5 Bushell-Embling, Dylan. "IQnovate signs first deal since NSX listing". Life Scientist. Retrieved 10 May 2013.
- 1 2 3 "IQnovate Ltd". Inside View. Archived from the original on 29 June 2013. Retrieved 10 May 2013.
- 1 2 3 4 "Who Are We?". IQnovate. Archived from the original on 30 May 2013. Retrieved 10 May 2013.
- 1 2 3 "What We Do". IQnovate. Archived from the original on 3 June 2013. Retrieved 10 May 2013.
- ↑ "IQnovate Limited". CROAsia.net. Retrieved 10 May 2013.